↓ Skip to main content

Cochrane Database of Systematic Reviews

Evaluation of follow‐up strategies for patients with epithelial ovarian cancer following completion of primary treatment

Overview of attention for article published in Cochrane database of systematic reviews, September 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
2 policy sources
twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
176 Mendeley
Title
Evaluation of follow‐up strategies for patients with epithelial ovarian cancer following completion of primary treatment
Published in
Cochrane database of systematic reviews, September 2014
DOI 10.1002/14651858.cd006119.pub3
Pubmed ID
Authors

Tilean Clarke, Khadra Galaal, Andrew Bryant, Raj Naik

Abstract

Ovarian cancer is the sixth most common cancer and seventh commonest cause of death in women worldwide. Traditionally, many people who have been treated for cancer undergo long-term follow-up in secondary care. However, it has been suggested that the use of routine review may not be effective in improving survival, quality of life (QoL), or relieving anxiety, or both. In addition, traditional follow-up may not be cost-effective.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 175 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 13%
Student > Bachelor 20 11%
Student > Ph. D. Student 17 10%
Researcher 14 8%
Other 10 6%
Other 28 16%
Unknown 64 36%
Readers by discipline Count As %
Medicine and Dentistry 59 34%
Nursing and Health Professions 14 8%
Psychology 13 7%
Agricultural and Biological Sciences 6 3%
Biochemistry, Genetics and Molecular Biology 4 2%
Other 14 8%
Unknown 66 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2023.
All research outputs
#5,189,339
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#7,107
of 11,499 outputs
Outputs of similar age
#50,367
of 250,219 outputs
Outputs of similar age from Cochrane database of systematic reviews
#138
of 218 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,219 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.